5,277 results match your criteria ASAIO journal American Society for Artificial Internal Organs : 1992[Journal]


ECMO Flow as a Sign of Intraabdominal Hemorrhage After Prolonged CPR.

ASAIO J 2018 Nov 28. Epub 2018 Nov 28.

From the Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Although life-saving, cardiopulmonary resuscitation (CPR) has been associated with traumatic injuries in adult patients surviving cardiac arrest. In addition to rib and sternal fractures, intraabdominal injuries have also been shown to occur, particularly after prolonged external cardiac massage. Early detection of these injuries remains difficult and is often masked by concomitant hemodynamic instability and the higher likelihood of other injuries such as retroperitoneal hemorrhage. Read More

View Article
November 2018
4 Reads

What Causes LVAD-Associated Ischemic Stroke? Surgery, Pump Thrombosis, Antithrombotics, and Infectionsa.

ASAIO J 2018 Nov 28. Epub 2018 Nov 28.

Cerebrovascular Center of the Neurological Institute, Cleveland Clinic, Cleveland, Ohio.

Acute ischemic stroke (AIS) is a major complication in left ventricular assist device (LVAD) population. A better understanding of clinical risk factors associated with AIS may help mitigate risk of stroke. We reviewed prospectively collected data of 477 LVAD patients from a tertiary center from October 1, 2004 to December 31, 2016. Read More

View Article
November 2018
1 Read

Outcomes of Repeat Left Ventricular Assist Device Exchange.

ASAIO J 2018 Nov 28. Epub 2018 Nov 28.

From the Division of Cardiothoracic Transplant and Assist Devices, Baylor College of Medicine.

Implantable continuous-flow left ventricular assist devices (CF-LVADs) are used for long-term LV support in bridging patients to heart transplantation or as destination therapy. With prolonged support times, some patients will have repeat complications necessitating multiple device exchanges. To elucidate the safety and efficacy of repeat device exchange, we retrospectively reviewed data from 25 patients who underwent two or more CF-LVAD implantations between July 2005 and August 2017. Read More

View Article
November 2018
1 Read

Tau Is Elevated in Pediatric Patients on Extracorporeal Membrane Oxygenation.

ASAIO J 2018 Nov 28. Epub 2018 Nov 28.

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.

Neurologic injury is a known and feared complication of extracorporeal membrane oxygenation (ECMO). Neurologic biomarkers may have a role in assisting with early identification of such. Axonal biomarker tau has not been investigated in the pediatric ECMO population. Read More

View Article
November 2018
2 Reads

Use of Hemodynamic Ramp Study to Optimize Continuous-Flow Ventricular Assist Device in a Fontan Patient.

ASAIO J 2018 Nov 21. Epub 2018 Nov 21.

From the Division of Pediatric Cardiology, CS Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan.

View Article
November 2018

Acute In Vivo Evaluation of the Pittsburgh Pediatric Ambulatory Lung.

ASAIO J 2018 Nov 21. Epub 2018 Nov 21.

From the McGowan Institute for Regenerative Medicine, Pittsburgh, Pennsylvania.

Respiratory failure is a significant problem within the pediatric population. A means of respiratory support that readily allows ambulation could improve treatment. The Pittsburgh Pediatric Ambulatory Lung (P-PAL) is being developed as a wearable pediatric pump-lung for long-term respiratory support and has previously demonstrated positive benchtop results. Read More

View Article
November 2018

Opening the "Dor," Not Always an Inferior Approach.

ASAIO J 2018 Nov 21. Epub 2018 Nov 21.

From the St. Vincent Hospital Indianapolis.

The Dor procedure was historically used to restore the geometry of the heart in a patient with a left ventricular (LV) aneurysm via reduction and reshaping of the LV with an aneurysmectomy. Unfortunately, morbidity and mortality remain high with this procedure, with many patients little to no recovery of their ejection fraction while developing severe diastolic failure, often requiring further support; however, the natural history of these patients remains largely unknown. Heart transplant has long been considered the most durable of treatment for patients with end-stage heart failure (HF), but because of the scarcity of donor hearts, the implantation of left ventricular assist devices (LVAD) for mechanical circulatory support has also proven to be an essential tool in the treatment of the advanced heart failure patient. Read More

View Article
November 2018
1 Read

Left Ventricular Assist Device Decommissioning Compared with Explantation for Ventricular Recovery: A Systematic Review.

ASAIO J 2018 Nov 27. Epub 2018 Nov 27.

From the Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.

Left ventricular assist device (LVAD) withdrawal with ventricular recovery represents the optimal outcome for patients previously implanted with an LVAD. The aim of this systematic review was to examine the patient outcomes of device withdrawal via minimally invasive pump decommissioning as compared with reoperation for pump explantation. An electronic search was performed to identify all studies in the English literature assessing LVAD withdrawal. Read More

View Article
November 2018
1.385 Impact Factor

Computed Tomography-Estimated Right Ventricular Function and Exercise Capacity in Patients with Continuous-Flow Left Ventricular Assist Devices.

ASAIO J 2018 Nov 27. Epub 2018 Nov 27.

From the Department of Cardiology.

Using four-dimensional (4D) cardiac computed tomography (CCT) scans at rest and immediately after exercise, we examined the right heart chamber sizes and systolic function and its association with exercise capacity in left ventricular assist device (LVAD) recipients. Fifteen patients with HeartMate (HM) II or 3 underwent echocardiography and maximal cardiopulmonary exercise test. Subsequently, contrast-enhanced CCT scans were performed at rest and immediately after two minutes of supine 25 Watt ergometer bike exercise. Read More

View Article
November 2018

Calcium Priming of the Central Venous Catheter Prevents a Drop in Ionized Calcium Concentration During Regional Citrate Anticoagulation.

ASAIO J 2018 Nov 7. Epub 2018 Nov 7.

Department of Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

During citrate-based Continuous Renal Replacement Therapy (CRRT), an infusion of calcium is necessary to replace the calcium lost in the effluent. The replacement takes place through a central venous catheter (CVC) that is primed with saline solution. Thus, we hypothesized a potential systemic anticoagulation because of unchelated citrate reaching the patient at the start of CRRT because of 0. Read More

View Article
November 2018
3 Reads

Extracorporeal Technologies Within the Social Media Labyrinth.

Authors:
Justyna Swol

ASAIO J 2018 Nov 7. Epub 2018 Nov 7.

Department of Respiratory Medicine, Allergology and Sleep Medicine, Paracelsus Medical University Nuremberg, General Hospital Nuremberg, Nuremberg, Germany.

View Article
November 2018
3 Reads

Obesity Is Associated with Driveline Infection of Left Ventricular Assist Devices.

ASAIO J 2018 Nov 5. Epub 2018 Nov 5.

From the Department of Advanced Cardiopulmonary Therapies and Transplantation, University of Texas-Houston McGovern Medical School and Memorial Hermann-Texas Medical Center, Houston, Texas.

In patients with left ventricular assist devices (LVADs), the association of driveline infection (DLI) and body mass index (BMI) remains controversial. The aim of this study was to explore a potential correlation between BMI and DLI in the LVAD patient population. A retrospective, single-center study evaluated patients who underwent LVAD implantation between May 2012 and July 2016. Read More

View Article
November 2018
2 Reads

Large Dual-Lumen Extracorporeal Membrane Oxygenation Cannulas Are Associated with More Intracranial Hemorrhage.

ASAIO J 2018 Nov 5. Epub 2018 Nov 5.

Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland.

Large dual-lumen veno-venous (VV) extracorporeal membrane oxygenation (ECMO) cannulas may increase venous pressure in the brain, contributing to intracranial hemorrhage (ICH). A retrospective cohort study was performed using the extracorporeal life support organization (ELSO) registry. Propensity score matching was used to control for confounding. Read More

View Article
November 2018
3 Reads

Erratum.

Authors:

ASAIO J 2018 Nov/Dec;64(6):e195

View Article
November 2018

Usefulness of Glycemic Control Using an Artificial Pancreas Apparatus for Cardiovascular Surgery.

ASAIO J 2018 Dec 6. Epub 2018 Dec 6.

From the Department of Cardiovascular Surgery, Hyogo College of Medicine, Nishinomiya City, Japan.

Blood glucose management is important for cardiovascular surgery using cardiopulmonary bypass. The usefulness of an artificial pancreas apparatus (STG-55) to control blood glucose in patients undergoing cardiopulmonary bypass was investigated. Subjects comprised 44 patients using the artificial pancreas during cardiopulmonary bypass between June 2016 and March 2017; 55 were initially enrolled, but 11 were excluded because of blood removal failure. Read More

View Article
December 2018
2 Reads

Surgical Techniques for Implanting the EVAHEART 2 Double Cuff Tipless Inflow Cannula.

ASAIO J 2018 Oct 31. Epub 2018 Oct 31.

From the Evaheart, Inc., Houston, Texas.

The EVAHEART 2 (Sun Medical Technology Research Corporation, Nagano, Japan) is an investigational centrifugal ventricular assist device in the United States, introduced a new type inflow, named "double cuff tipless" inflow cannula intended to mitigate the risks of cannula malposition and subsequent ischemic stroke events associated with thrombi around the inflow cannula. To achieve these performance benefits of the "tipless" design, however, it is crucial to adhere to the recommended surgical procedure. We introduced a polymer-based patient model that mimics a dilated cardiomyopathy apex for inflow cannula implantation training. Read More

View Article
October 2018
5 Reads

Lung Biopsy in Patients with Acute Respiratory Distress Syndrome Supported on Extracorporeal Membrane Oxygenation: A 2 Year Experience.

ASAIO J 2018 Oct 31. Epub 2018 Oct 31.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article
October 2018
1 Read

Unclear Benefit of Cardiac Resynchronization Therapy in Patients with Implanted Left Ventricular Assist Devices.

ASAIO J 2018 Aug 14. Epub 2018 Aug 14.

Division of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

View Article
August 2018
1 Read

Passive Leg Raising After Left Ventricular Assist Device Implantation.

ASAIO J 2018 Aug 14. Epub 2018 Aug 14.

Department of Cardiac Surgery, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Israel.

Left ventricular assist device (LVAD) implantation is a common procedure in patients with end-stage heart failure. Although optimal fluid management is essential for acceptable postoperative treatment, it is critical to identify which patients will benefit from fluid administration. Passive leg raising (PLR) is a validated dynamic method that predicts fluid responsiveness in patients with heart failure by inducing a transient increase in cardiac preload. Read More

View Article
August 2018
1 Read

Fluid Balance and Recovery of Native Lung Function in Adult Patients Supported by Venovenous Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

ASAIO J 2018 Aug 14. Epub 2018 Aug 14.

From the Department of Critical Care Medicine, Mater Misericordiae University Hospital, Dublin.

Fluid overload is associated with increased mortality in adult patients with acute respiratory distress syndrome. In patients requiring venovenous extracorporeal membrane oxygenation (VV-ECMO), the effects of fluid removal on survival and lung recovery remain undefined. We assessed the impact of early fluid removal in adult patients supported by VV-ECMO and concomitant continuous renal replacement therapy, in an 18-bed tertiary intensive care unit between 2010 and 2015. Read More

View Article
August 2018
10 Reads

Left Ventricular Ejection Fraction Depends on Loading Conditions.

ASAIO J 2018 Oct 16. Epub 2018 Oct 16.

Medical Intensive Care Unit, Department of Medicine, University Hospital of Liège, Liege, Belgium.

View Article
October 2018

Hemoadsorption does not Affect Hemolysis During Cardiopulmonary Bypass.

ASAIO J 2018 Oct 8. Epub 2018 Oct 8.

From the Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.

Cardiopulmonary bypass (CPB) induces hemolysis, which manifests as plasma free hemoglobin. We investigated in a post hoc analysis of a single-center, blinded, controlled study whether the use of a novel hemoadsorption device (CytoSorb, CytoSorbents Europe GmbH, Berlin, Germany) affects hemolysis during CPB. A total of 35 patients undergoing elective CPB surgery with an expected CPB duration of more than 120 min were included in the analysis. Read More

View Article
October 2018
4 Reads

Suitability of 3D-Printed Root Models for the Development of Transcatheter Aortic Root Repair Technologies.

ASAIO J 2018 Oct 10. Epub 2018 Oct 10.

Cardiovascular Research Unit, University Hospital of Lausanne, Lausanne, Switzerland.

Transcatheter aortic root repair (TARR) is still not available because of the complex anatomy. In order to develop future TARR technologies, a human-derived bench test model is required before performing animal tests. For this purpose, we aimed to validate computed tomography (CT)-derived 3D-printed root models for TARR technologies. Read More

View Article
October 2018
1 Read

Preoperative Predictors of Mortality in Short-Term Continuous-Flow Ventricular Assist Devices.

ASAIO J 2018 Oct 10. Epub 2018 Oct 10.

Division of Cardiology, Division of Pediatric Cardiology, University of Alberta, Edmonton, Alberta, Canada.

Short-term continuous-flow ventricular assist devices (STCF-VADs) are increasingly being utilized to support critically ill patients, despite limited information regarding overall outcomes. All adult patients supported with an STCF-VAD between June 2009 and December 2015 were included in this retrospective single-center study. Associations between preoperative characteristics and unsuccessful bridge (death on device or within 30 days postdecannulation) were assessed using logistic regression. Read More

View Article
October 2018
10 Reads

Extracorporeal Membrane Oxygenation for Adults With Refractory Septic Shock.

ASAIO J 2018 Oct 10. Epub 2018 Oct 10.

From the Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain; and Shock, Organ Dysfunction, and Resuscitation Research Group, Department of Medicine, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.

Because of a severe dysregulation of the host response to infection, septic shock may induce a profound imbalance between oxygen consumption and delivery, which in some cases may be refractory to conventional support measures. In this setting, extracorporeal membrane oxygenation (ECMO) may help to restore this ratio. Indeed, in neonates and children, this technique is already established as a valid salvage therapy. Read More

View Article
October 2018
10 Reads

Left Ventricular Assist Devices; How Do We Define Success?

ASAIO J 2018 Oct 9. Epub 2018 Oct 9.

From the Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.

Despite the growing acceptance of left ventricular assist device (LVAD) therapy to improve survival and quality of life in heart failure (HF) patients, uncertainties persist regarding the definition of a successful implant. We sought to define an innovative approach to assess success and subsequently compare preoperative variables affecting outcomes. From January 2007 to 2015, 278 patients underwent LVAD implantation. Read More

View Article
October 2018
5 Reads

Impact of Diabetes Mellitus on Survival in Patients Bridged to Transplantation with Left Ventricular Assist Devices in the United States.

ASAIO J 2018 Nov 30. Epub 2018 Nov 30.

Department of Adult Cardiology, Adult Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Diabetes mellitus (DM) is associated with increased mortality in advanced heart failure and in patients undergoing cardiac surgery. However, its impact on outcomes in patients supported with left ventricular assist devices (LVAD) is not well established. We queried the United Network for Organ Sharing (UNOS) for all adults listed for heart transplantation and bridged with continuous-flow LVAD in the United States from 2000 to 2015. Read More

View Article
November 2018
1 Read

The Impact of Infection and Elevated INR in LVAD-Associated Intracranial Hemorrhage: A Case-Crossover Study.

ASAIO J 2018 Oct 9. Epub 2018 Oct 9.

Neurological Institute, Cleveland Clinic, Cleveland, Ohio.

Despite the common occurrence left ventricular assist device (LVAD)-associated intracranial hemorrhage, the etiology of intracranial hemorrhage is uncertain. We aim to explore the impact of infection and international normalized ratio (INR) on intracranial hemorrhage in a case-crossover study. We reviewed consecutive patients with intracranial hemorrhage in a prospectively collected data of LVAD patients from a single, tertiary center from October 2004 to December 2016. Read More

View Article
October 2018
7 Reads

Intravenous Versus Oral Iron Replacement in Patients with a Continuous-Flow Left Ventricular Assist Device.

ASAIO J 2018 Oct 9. Epub 2018 Oct 9.

From the University of North Carolina Medical Center.

View Article
October 2018
2 Reads
1.380 Impact Factor

The Physiologic Basis of Ejection Fraction.

Authors:
Hoong Sern Lim

ASAIO J 2018 Oct 9. Epub 2018 Oct 9.

Queen Elizabeth Hospital Birmingham, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham, United Kingdom,

View Article
October 2018

Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy.

ASAIO J 2018 Oct 9. Epub 2018 Oct 9.

Department of Surgery, Columbia University Medical Center, New York, New York.

Chronic systolic heart failure (HF) with acute decompensation can result in cardiogenic shock (CS) requiring short-term mechanical circulatory support. We sought to identify predictors of survival for acute decompensated HF (ADHF) patients requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Patients >18 years old treated at our institution with VA-ECMO from 2009 to 2018 for ADHF with CS were studied. Read More

View Article
October 2018
7 Reads

Yellow Means Caution: Correlations Between Liver Injury and Mortality with the Use of VA-ECMO.

ASAIO J 2018 Oct 9. Epub 2018 Oct 9.

Center for Advanced Heart Failure, Memorial Hermann Hospital-Texas Medical Center, Houston, Texas.

Abnormalities in markers of liver injury after venoarterial extracorporeal membrane oxygenation (VA-ECMO) initiation are of unclear distribution and clinical significance. This study included all consecutive adult patients from a single institution who underwent VA-ECMO cannulation between May 2012 and September 2016 and had liver function panels drawn during their admission (n = 223). Data points include: age, sex, body mass index, diagnosis, duration of ECMO cannulation, duration of hospitalization, pre-ECMO cardiac arrest, central nervous system (CNS) injury, the presence of chronic kidney disease or acute renal failure, renal replacement therapy utilization, lactate levels, duration of pre-ECMO intubation, admission and peak bilirubin/aspartate aminotransferase (AST)/alanine aminotransferase (ALT)/alkaline phosphatase (ALP) levels, and time to peak bilirubin/AST/ALT/ALP in relation to cannulation. Read More

View Article
October 2018
2 Reads

Chronic In Vivo Test of a Right Heart Replacement Blood Pump for Failed Fontan Circulation.

ASAIO J 2018 Oct 3. Epub 2018 Oct 3.

From the Department of Surgery, Penn State College of Medicine, Hershey, Pennsylvania.

An implantable rotary blood pump was developed to provide long-term mechanical right heart support for patients who have failing Fontan circulation. The objective of this study was to evaluate the pump in vivo in a 30 day sheep study. Pump speed was set at 3,900 rpm for the duration of the study, and pump power was between 4. Read More

View Article
October 2018
10 Reads

Bivalirudin in Extracorporeal Life Support: Response and Considerations.

ASAIO J 2018 Oct 3. Epub 2018 Oct 3.

Department of Pharmacy, University of California Davis Medical Center, Sacramento, California,

View Article
October 2018

Management of RVAD Thrombosis in Biventricular HVAD Supported Patients: Case Series.

ASAIO J 2018 Oct 3. Epub 2018 Oct 3.

From the Cardiology Division, Department of Medicine, University of California San Diego, La Jolla, California.

Patients with biventricular assist devices (BIVAD) are severely critically ill compared with patients who receive left ventricular assist device (LVAD) support alone and portend a significant risk for greater adverse events including pump thrombosis (PT). Current approaches to treat PT are limited to LVAD with variable outcomes depending on the management strategy implemented. Moreover the management of PT in patients with BIVAD support, specifically to the right ventricular assist device (RVAD), is unknown. Read More

View Article
October 2018
1 Read

Bivalirudin and ECLS: Commentary and Considerations.

ASAIO J 2018 Oct 3. Epub 2018 Oct 3.

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, Department of Cardiovascular Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota Department of Pharmacy, Mayo Clinic, Rochester, Minnesota.

View Article
October 2018

Pharmacokinetics of Sildenafil in Patients with a Left Ventricular Assist Device: A Word of Caution.

ASAIO J 2018 Oct 3. Epub 2018 Oct 3.

Lipscomb University College of Pharmacy, Nashville, Tennessee.

We compared maximal plasma concentrations (Cmax) of sildenafil and metabolite n-desmethyl sildenafil in 12 inpatients with left ventricular assist devices (LVADs) on sildenafil (60 mg/day) to the reference range. Sildenafil Cmax (156.8 ± 124. Read More

View Article
October 2018
1 Read

Evaluation of 30 Day Readmissions After Index Ventricular Assist Device Implantation in the United States.

ASAIO J 2018 Oct 3. Epub 2018 Oct 3.

Cedars-Sinai Heart Institute, Los Angeles, California.

Ventricular assist device (VAD) implantation has improved quality of life and short-term survival for advanced heart failure patients. There are limited data from single-center studies addressing the characteristics and etiologies of 30 day readmissions after VAD implant. We used the Nationwide Readmissions Database (NRD) 2014 to identify insertion of implantable heart assist system during index admission. Read More

View Article
October 2018
1 Read

Anything Goes? High Time for Smart Blood Volume Monitors.

ASAIO J 2018 Nov/Dec;64(6):697-700

Department of Medicine III, Clinical Division of Nephrology & Dialysis, Medical University of Vienna, Vienna, Austria.

View Article
October 2018
3 Reads

Development and Validation of a Life-Sized Mock Circulatory Loop of the Human Circulation for Fluid-Mechanical Studies.

ASAIO J 2018 Sep 28. Epub 2018 Sep 28.

From the Department of Adult and Pediatric Cardiovascular Surgery, University Hospital Giessen, Giessen, Germany.

Mock circulatory loops (MCLs) are usually developed for assessment of ventricular assist devices and consist of abstracted anatomical structures represented by connecting tubing pipes and controllable actuators which could mimic oscillating flow processes. However, with increasing use of short-term peripheral mechanical support (extracorporeal life support [ECLS]) and the upcoming evidence of even counteracting flow processes between the failing native circulation and ECLS, MCLs incorporating the peripheral vascular system and preserved anatomical structures are becoming more important for systematic assessment of these processes. For reproducible and standardized fluid-mechanical studies using magnetic resonance imaging, Doppler ultrasound, and computational fluid dynamics measurements, we developed a MCL of the human circulation. Read More

View Article
September 2018
1 Read

An Innovative Ventricular Assist Device Strategy as a Bridge-to-Recovery in an Infant with Glenn Physiology.

ASAIO J 2018 Sep 28. Epub 2018 Sep 28.

From the Division of Pediatric Cardiothoracic Surgery, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis, Tennessee.

Mechanical circulatory support for infants with single ventricle physiology remains challenging. Utilization of a ventricular assist device (VAD) has potential advantages over extracorporeal circulatory membrane oxygenation. As such, VAD utilization in single ventricle patients with refractory heart failure continues to be explored. Read More

View Article
September 2018
2 Reads

A Proof of Concept Study, Demonstrating Extracorporeal Carbon Dioxide Removal Using Hemodialysis with a Low Bicarbonate Dialysate.

ASAIO J 2018 Sep 28. Epub 2018 Sep 28.

Center for Critical Care Nephrology, Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Extracorporeal carbon dioxide removal (ECCO2R) devices remove CO2 directly from blood, facilitating ultraprotective ventilation or even providing an alternative to mechanical ventilation. However, ECCO2R is not widely available, whereas dialysis is available in most intensive care units (ICUs). Prior attempts to provide ECCO2R with dialysis, by removing CO2 in the form of bicarbonate, have been plagued by metabolic acidosis. Read More

View Article
September 2018
11 Reads

Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation.

ASAIO J 2018 Sep 28. Epub 2018 Sep 28.

Division of Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, California.

Temporary mechanical circulatory support (MCS) can be a bridge to decision for patients in severe cardiogenic shock who may be eligible for durable support or transplantation. Outcomes with Impella microaxial devices for salvage of severe shock in the end-stage heart failure population are not well described. Patients who underwent Impella placement as a bridge to decision, durable MCS, or transplantation were included. Read More

View Article
September 2018
2 Reads

Survival and Functional Status After Bridge-to-Transplant with a Left Ventricular Assist Device.

ASAIO J 2018 Sep 28. Epub 2018 Sep 28.

From the Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

The use left ventricular assist devices (LVAD) as a bridge-to-transplant (BTT) has become a common modality to treat end-stage heart failure. We sought to examine the impact of BTT on long-term survival and quality of life after heart transplant. The population was all adult patients undergoing isolated heart transplantation in the United States between 2007 and 2017. Read More

View Article
September 2018
1 Read

Pediatric Femoral Arterial Cannulations in Extracorporeal Membrane Oxygenation: A Review and Strategies for Optimization.

ASAIO J 2018 Sep 19. Epub 2018 Sep 19.

From the Department of Surgery, The Johns Hopkins Hospital, Baltimore, Maryland.

Venoarterial (VA) extracorporeal membrane oxygenation (ECMO) is a treatment strategy for pediatric patients with cardiopulmonary failure. Femoral cannulation is a commonly used technique for obtaining central access in children and adolescents despite high rates of vascular complications. Ischemic limb complications remain one of the most common problems facing survivors of femoral VA ECMO. Read More

View Article
September 2018
3 Reads

QRS Shortens after Left Ventricular Assist Device Implantation.

ASAIO J 2018 Sep 19. Epub 2018 Sep 19.

Department of Cardiology, Lexington, Kentucky.

View Article
September 2018
2 Reads

Trends in Extracorporeal Membrane Oxygenation Growth in the United States, 2011-2014.

ASAIO J 2018 Sep 19. Epub 2018 Sep 19.

From the Department of Anesthesiology, Emory School of Medicine, Atlanta, Georgia.

The use of extracorporeal membrane oxygenation (ECMO) has grown rapidly in recent years. We sought to describe the rate of ECMO use in the United States, regional variation in ECMO use, the hospitals performing ECMO, and the primary payers for ECMO patients. Detailed data were obtained using the Healthcare Cost and Utilization Project (HCUPnet) summaries of State Inpatient Databases from 34 participating states for the years 2011-2014. Read More

View Article
September 2018
9 Reads

Quality Over Quantity: Standardization of Pediatric HeartWare Ventricular Assist Device Dressing Changes.

ASAIO J 2018 Nov/Dec;64(6):e181-e186

From the Cardiac Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Pediatric patients are unique both in their diagnosis and clinical presentation before implantation of a ventricular assist device (VAD) and in their driveline site characteristics post-implant. There is limited evidence in scholarly literature that describes complications of pediatric VAD driveline sites or approaches by which to manage them. The Cardiac Center at The Children's Hospital of Philadelphia (CHOP) follows a standard of care for HeartWare VAD (HVAD) dressing changes in the inpatient setting with the goal of transitioning patients to weekly dressing changes by the time they are discharged to home. Read More

View Article
September 2018
6 Reads

Marked Practice Variation in Antithrombotic Care with the Berlin Heart EXCOR Pediatric Ventricular Assist Device.

ASAIO J 2018 Sep 12. Epub 2018 Sep 12.

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Palo Alto, California.

Management of antithrombotic therapy (ATT) for pediatric ventricular assist devices is challenging, and the Berlin EXCOR remains the only FDA-approved option. Among those on the EXCOR, 28% have neurologic complications and major bleeding occurs in 50%. The Edmonton Protocol was developed to guide ATT, but the adverse event rate remains high, leading most centers to make modifications. Read More

View Article
September 2018
6 Reads

Conduction Abnormalities Associated with Tricuspid Annuloplasty in Cardiac Transplantation.

ASAIO J 2018 Sep 17. Epub 2018 Sep 17.

From the Department of Medicine-Cardiology, Columbia University Medical Center, New York, New York.

Prophylactic DeVega tricuspid annuloplasty (DVA) of the donor heart has been reported to improve tricuspid regurgitation (TR), renal dysfunction, and mortality in cardiac transplant recipients. This is the first study to investigate the electrical, as well as, hemodynamic effects of DVA during orthotopic heart transplantation (OHT). Electrocardiographic, echocardiographic, and hemodynamic data of 76 patients with DVA and 104 patients without DVA who underwent OHT between 2013 and 2017 at Columbia University Medical Center (New York, NY) were studied. Read More

View Article
September 2018
1 Read
1.380 Impact Factor